Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States (CDC)
Clinical Guidance - DC DOH Resources
Summary of recent changes (last updated September 6, 2024):
Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older
Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances
